SONN — Sonnet Biotherapeutics Holdings Share News
0.000.00%
Last trade - 00:00- $26.33m
- $26.01m
- $0.02m
Brief: Sonnet Biotherapeutics Holdings Says Got Letter From Nasdaq Notifying Failure To Satisfy Continued Listing Rule Or Standard
Sonnet Biotherapeutics Holdings Inc expected to post a loss of 76 cents a share - Earnings Preview
Brief: Sonnet Biotherapeutics Reports Data From Phase 1b/2a Clinical Trial Of SON-080
Brief: Sonnet Biotherapeutics Holdings Announces Review Of Strategic Alternatives
Sonnet Biotherapeutics Holdings Inc reports results for the quarter ended in March - Earnings Summary
Sonnet Biotherapeutics Holdings Inc expected to post earnings of 14 cents a share - Earnings Preview
Brief: Sonnet Biotherapeutics Early Safety Data From Co’S Phase 1B/2A Clinical Trial Of Son-080 In Cipn Met Study’S Initial Pre-Specified Objective
Sonnet Biotherapeutics Holdings Inc reports results for the quarter ended in December - Earnings Summary
Brief: Sonnet Biotherapeutics Holdings Inc - QTRLY Loss Per Share $0.31
Sonnet Biotherapeutics Holdings Inc expected to post a loss of 90 cents a share - Earnings Preview
Brief: Sonnet Biotherapeutics Received Letter From Nasdaq That Co Regained Compliance With Stockholders' Equity Requirement
Brief: Sonnet Biotherapeutics Holdings Files For Mixed Shelf Of Up To $100 mln - SEC Filing
Brief: Sonnet Biotherapeutics Gets Nasdaq Notice On Non-Compliance With Minimum Stockholders' Equity Requirement
Sonnet Biotherapeutics Holdings Inc reports results for the quarter ended in September - Earnings Summary
Brief: Sonnet Biotherapeutics Expect To Be Able To Share Safety Data From Sb102 And Sb221 Studies
Sonnet Biotherapeutics Holdings Inc expected to post a loss of $4.09 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Microsoft, Gap, Alphabet
Brief: Sonnet Biotherapeutics Holdings says Received Formal Notice From Nasdaq Indicating That Co Has Regained Compliance With Nasdaq Listing Rule 5550(A)(2)
Sonnet Biotherapeutics Holdings Inc reports results for the quarter ended in June - Earnings Summary